These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 9119996)
1. Epstein-Barr virus-specific cytotoxic T cell responses in HIV-1 infection: different kinetics in patients progressing to opportunistic infection or non-Hodgkin's lymphoma. Kersten MJ; Klein MR; Holwerda AM; Miedema F; van Oers MH J Clin Invest; 1997 Apr; 99(7):1525-33. PubMed ID: 9119996 [TBL] [Abstract][Full Text] [Related]
2. Assessment and characterization of the cytolytic T lymphocyte response against Epstein-Barr virus in patients with non-Hodgkin's lymphoma after autologous peripheral blood stem cell transplantation. Nolte A; Buhmann R; Straka C; Emmerich B; Hallek M Bone Marrow Transplant; 1998 May; 21(9):909-16. PubMed ID: 9613783 [TBL] [Abstract][Full Text] [Related]
3. Establishment of cytotoxic T lymphocytes specific for autologous Epstein-Barr virus in HIV-infected patients: the feasibility study of EBV-specific immunotherapy for patients with EBV-associated lymphoma. Hansasuta P; Incomserb P; Buranapraditkun S; Bhattarakosol P J Med Assoc Thai; 2004 Sep; 87 Suppl 2():S146-51. PubMed ID: 16083179 [TBL] [Abstract][Full Text] [Related]
4. A longitudinal and prospective study of Epstein-Barr virus load in AIDS-related non-Hodgkin lymphoma. Bonnet F; Jouvencel AC; Parrens M; Leon MJ; Cotto E; Garrigue I; Morlat P; Beylot J; Fleury H; Lafon ME J Clin Virol; 2006 Aug; 36(4):258-63. PubMed ID: 16762591 [TBL] [Abstract][Full Text] [Related]
5. Hepatitis C virus-Epstein-Barr virus interaction in patients with AIDS. Challine D; Buisson M; Cadilhac M; Germanidis G; Joab I; Eliaszewicz M; Caumes E; Flahault A; Fillet AM; Pawlotsky JM; Seigneurin JM J Med Virol; 2002 Aug; 67(4):510-5. PubMed ID: 12115996 [TBL] [Abstract][Full Text] [Related]
6. [Lymphoma genesis in the context of HIV infection]. Besson C; Raphaël M Ann Med Interne (Paris); 2003 Dec; 154(8):523-8. PubMed ID: 15037828 [TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study. Leong IT; Fernandes BJ; Mock D Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):184-93. PubMed ID: 11505266 [TBL] [Abstract][Full Text] [Related]
8. Dysfunctional Epstein-Barr virus (EBV)-specific CD8(+) T lymphocytes and increased EBV load in HIV-1 infected individuals progressing to AIDS-related non-Hodgkin lymphoma. van Baarle D; Hovenkamp E; Callan MF; Wolthers KC; Kostense S; Tan LC; Niesters HG; Osterhaus AD; McMichael AJ; van Oers MH; Miedema F Blood; 2001 Jul; 98(1):146-55. PubMed ID: 11418474 [TBL] [Abstract][Full Text] [Related]
9. Immunological characterization of Hodgkin's and non-Hodgkin's lymphoma patients with high antibody titers against Epstein-Barr virus-associated antigens. Masucci G; Mellstedt H; Masucci MG; Szigeti R; Ernberg I; Björkholm M; Tsukuda K; Henle G; Henle W; Pearson G Cancer Res; 1984 Mar; 44(3):1288-300. PubMed ID: 6318984 [TBL] [Abstract][Full Text] [Related]
10. Expression of the simian Epstein-Barr virus-encoded latent membrane protein-1 in malignant lymphomas of SIV-infected rhesus macaques. Blaschke S; Hannig H; Buske C; Kaup FJ; Hunsmann G; Bodemer W J Med Virol; 2001 Sep; 65(1):114-20. PubMed ID: 11505452 [TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr viral load as a marker of lymphoma in AIDS patients. Fan H; Kim SC; Chima CO; Israel BF; Lawless KM; Eagan PA; Elmore S; Moore DT; Schichman SA; Swinnen LJ; Gulley ML J Med Virol; 2005 Jan; 75(1):59-69. PubMed ID: 15543571 [TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus-specific cytotoxic T lymphocyte responses in the blood and tumor site of Hodgkin's disease patients: implications for a T-cell-based therapy. Chapman AL; Rickinson AB; Thomas WA; Jarrett RF; Crocker J; Lee SP Cancer Res; 2001 Aug; 61(16):6219-26. PubMed ID: 11507075 [TBL] [Abstract][Full Text] [Related]
14. Circulating Epstein-Barr virus (EBV) in HIV-infected patients and its relation with primary brain lymphoma. Fellner MD; Durand K; Correa RM; Redini L; Yampolsky C; Colobraro A; Sevlever G; Teyssié AR; Benetucci J; Picconi MA Int J Infect Dis; 2007 Mar; 11(2):172-8. PubMed ID: 16931088 [TBL] [Abstract][Full Text] [Related]
15. [Epstein-Barr virus-specific immunity in asymptomatic carriers of human T-cell leukemia virus type 1]. Kwon KW Hokkaido Igaku Zasshi; 1995 Mar; 70(2):315-28. PubMed ID: 7774883 [TBL] [Abstract][Full Text] [Related]
16. Correlation of immunophenotype of sinonasal non-Hodgkin's lymphoma to Epstein-Barr virus infection. Feng YF; Wu QL; Zong YS Ai Zheng; 2007 Nov; 26(11):1170-6. PubMed ID: 17991313 [TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus and human immunodeficiency virus serological responses and viral burdens in HIV-infected patients treated with HAART. O'Sullivan CE; Peng R; Cole KS; Montelaro RC; Sturgeon T; Jenson HB; Ling PD J Med Virol; 2002 Jul; 67(3):320-6. PubMed ID: 12116021 [TBL] [Abstract][Full Text] [Related]
18. Epstein-barr virus-associated non-Hodgkin's lymphoma of B-cell origin, Hodgkin's disease, acute leukemia, and systemic lupus erythematosus: a serologic and molecular analysis. Mitarnun W; Pradutkanchana J; Takao S; Saechan V; Suwiwat S; Ishida T J Med Assoc Thai; 2002 May; 85(5):552-9. PubMed ID: 12188384 [TBL] [Abstract][Full Text] [Related]
19. Dynamics of cytomegalovirus (CMV)-specific T cells in HIV-1-infected individuals progressing to AIDS with CMV end-organ disease. Bronke C; Palmer NM; Jansen CA; Westerlaken GH; Polstra AM; Reiss P; Bakker M; Miedema F; Tesselaar K; van Baarle D J Infect Dis; 2005 Mar; 191(6):873-80. PubMed ID: 15717261 [TBL] [Abstract][Full Text] [Related]
20. Loss of T-cell cytotoxic responses in the course of HIV-1 infection. Zerhouni B; Sanhadji K; Touraine JL Thymus; 1997; 24(4):203-19. PubMed ID: 9493284 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]